A 46 (Glyburide and metformin hydrochloride 1.25 mg / 250 mg)

Pill imprint A 46 has been identified as Glyburide and metformin hydrochloride 1.25 mg / 250 mg.

Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glyburide/metformin 1.25 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Glyburide and metformin hydrochloride

Imprint:

A 46

Strength:

1.25 mg / 250 mg

Color:

Yellow

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Antidiabetic combinations

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Aurobindo Pharma

National Drug Code (NDC):

65862-0080

Inactive Ingredients:

microcrystalline cellulose
croscarmellose sodium
povidone k90
magnesium stearate
hypromellose 2910 (6 mPa.s)
propylene glycol
polysorbate 80
magnesium silicate
titanium dioxide
FD&C Yellow No. 6
D&C Yellow No. 10

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.